Skip to main content
Erschienen in: Rheumatology International 10/2012

01.10.2012 | Original Article

Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud’s phenomenon

verfasst von: Slavica Pavlov-Dolijanovic, Nemanja S. Damjanov, Roksanda M. Stojanovic, Nada Z. Vujasinovic Stupar, Dejana M. Stanisavljevic

Erschienen in: Rheumatology International | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

To assess the prognostic value of scleroderma pattern of nailfold capillary changes for the development of connective tissue diseases (CTD) in subjects with primary Raynaud’s phenomenon (RP). The study included 3,029 consecutive patients with primary RP who had been followed at 6-month intervals during the mean of 4.8 years. The pathological features of nailfold capillaroscopy were recorded in all patients who had neither clinical nor serological signs of a CTD. In patients who developed CTD, capillary changes obtained 6 months prior to diagnosis were analyzed. A possible relationship between capillary changes and the presence of associated CTD was assessed. At the end of follow-up, 1,660 (54,8%) patients have still the primary RP, 246 (8,1%) had suspected secondary RP, and 1,123 (37,1%) patients developed CTD (363 undifferentiated CTD, 263 systemic sclerosis, 143 systemic lupus erythematosus, 106 rheumatoid arthritis, 102 Sjögren’s syndrome, 61 overlap syndrome, 30 vasculitides, 24 mixed CTD, 19 polymyositis, 7 dermatomyositis, and 5 primary antiphospholipid syndrome). Scleroderma pattern were significantly associated with the development of systemic sclerosis [P = .00001, sensitivity 94%, specificity 92%, positive predictive value 52%, negative predictive value 99%, and odds ratio 163 (95% CI, 97,9–271,5)], as well as dermatomyositis (P = .0004), overlap syndrome with signs of systemic sclerosis (P = .0001), and mixed connective tissue disease (P = .007). Capillary microscopy is effective method for differentiation between primary and secondary RP and useful tool for the prediction of scleroderma spectrum disorders in RP patients.
Literatur
2.
Zurück zum Zitat Maricq HR, Weinberg AB, LeRoy EC (1982) Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud’s phenomenon. J Rheumatol 9:289–291PubMed Maricq HR, Weinberg AB, LeRoy EC (1982) Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud’s phenomenon. J Rheumatol 9:289–291PubMed
3.
Zurück zum Zitat Kallenberg CG, Pastoor GW, Wouda AA (1982) Antinuclear antibodies in patients with Raynaud’s phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis 41:382–387PubMedCrossRef Kallenberg CG, Pastoor GW, Wouda AA (1982) Antinuclear antibodies in patients with Raynaud’s phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis 41:382–387PubMedCrossRef
4.
Zurück zum Zitat Porter JM, Bardana EJ Jr, Baur GM, Wesche DH, Andrasch RH, Rosch J (1976) The clinical significance of Raynaud’s syndrome. Surgery 80:756–764PubMed Porter JM, Bardana EJ Jr, Baur GM, Wesche DH, Andrasch RH, Rosch J (1976) The clinical significance of Raynaud’s syndrome. Surgery 80:756–764PubMed
5.
Zurück zum Zitat Zufferey P, Depairon M, Chamot AM, Monti M (1992) Prognostic significance of nailfold capillary microscopy in patients with Raynaud’s phenomenon and scleroderma pattern abnormalities: a six-years follow-up study. Clin Rheumatol 11:536–541PubMedCrossRef Zufferey P, Depairon M, Chamot AM, Monti M (1992) Prognostic significance of nailfold capillary microscopy in patients with Raynaud’s phenomenon and scleroderma pattern abnormalities: a six-years follow-up study. Clin Rheumatol 11:536–541PubMedCrossRef
6.
Zurück zum Zitat Spencer-Green G (1998) Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158:595–600PubMedCrossRef Spencer-Green G (1998) Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158:595–600PubMedCrossRef
7.
Zurück zum Zitat Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthr Rheum 48:3023–3030CrossRef Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthr Rheum 48:3023–3030CrossRef
8.
Zurück zum Zitat Maricq HR, Spencer-Green G, LeRoy EC (1976) Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud syndrome and dermatomyositis. Am J Med 61:862–870PubMedCrossRef Maricq HR, Spencer-Green G, LeRoy EC (1976) Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud syndrome and dermatomyositis. Am J Med 61:862–870PubMedCrossRef
9.
Zurück zum Zitat Maricq HR, LeRoy EC, D’Angelo WA et al (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthr Rheum 23:183–189CrossRef Maricq HR, LeRoy EC, D’Angelo WA et al (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthr Rheum 23:183–189CrossRef
10.
Zurück zum Zitat Houtman PM, Kallenberg CGM, Wouda AA, The TH (1985) Decreased nailfold capillary density in Raynaud phenomenon: a reflection of immunologically mediated local and systemic vascular disease. Ann Rheum Dis 44:603–609PubMedCrossRef Houtman PM, Kallenberg CGM, Wouda AA, The TH (1985) Decreased nailfold capillary density in Raynaud phenomenon: a reflection of immunologically mediated local and systemic vascular disease. Ann Rheum Dis 44:603–609PubMedCrossRef
11.
Zurück zum Zitat Meli M, Gityelmann G, Koppensteiner R, Amann-Vesti BR (2006) Predictive value of nailfold capillaroscopy in patients with Raynaud’s phenomenon. Clin Rheumatol 25:153–158PubMedCrossRef Meli M, Gityelmann G, Koppensteiner R, Amann-Vesti BR (2006) Predictive value of nailfold capillaroscopy in patients with Raynaud’s phenomenon. Clin Rheumatol 25:153–158PubMedCrossRef
12.
Zurück zum Zitat LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed
13.
Zurück zum Zitat Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthr Rheum 24:1159–1164CrossRef Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthr Rheum 24:1159–1164CrossRef
14.
Zurück zum Zitat Damjanov N, Pavlov S, Radosavljevic V, Ostojic P, Curcic A (1998) Prognostic significance of capillaroscopic findings in subjects with Raynaud phenomenon. Acta Rheumatol Belgradensia 28:12–17 Damjanov N, Pavlov S, Radosavljevic V, Ostojic P, Curcic A (1998) Prognostic significance of capillaroscopic findings in subjects with Raynaud phenomenon. Acta Rheumatol Belgradensia 28:12–17
15.
Zurück zum Zitat LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 15:202–205PubMed
16.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 25:1271–1277CrossRef Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 25:1271–1277CrossRef
17.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324CrossRef Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324CrossRef
18.
Zurück zum Zitat Alarcon-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334PubMed Alarcon-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334PubMed
19.
Zurück zum Zitat Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407PubMedCrossRef Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407PubMedCrossRef
20.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-Europe Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-Europe Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef
21.
Zurück zum Zitat Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheum 17:615–620 Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheum 17:615–620
22.
Zurück zum Zitat Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthr Rheum 42:1309–1311CrossRef Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthr Rheum 42:1309–1311CrossRef
23.
Zurück zum Zitat Campbell G (1994) Advances in statistical methodology for the evaluation of diagnosis and laboratory test. Stat Med 13:499–508PubMedCrossRef Campbell G (1994) Advances in statistical methodology for the evaluation of diagnosis and laboratory test. Stat Med 13:499–508PubMedCrossRef
24.
Zurück zum Zitat Cervini C, Grassi W (1996) Raynaud’s phenomenon. Rheumatol Eur 25:111–113 Cervini C, Grassi W (1996) Raynaud’s phenomenon. Rheumatol Eur 25:111–113
25.
Zurück zum Zitat Maricq HR, Weinrich MC, Keli JE, LeRoy EC (1986) Prevalence of Raynaud’s phenomenon in the general population. J Chron Dis 39:423–427PubMedCrossRef Maricq HR, Weinrich MC, Keli JE, LeRoy EC (1986) Prevalence of Raynaud’s phenomenon in the general population. J Chron Dis 39:423–427PubMedCrossRef
26.
Zurück zum Zitat Harper FE, Maricq HR, Turner RE, Lidman RW, LeRoy EC (1982) A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. Am J Med 72:883–888PubMedCrossRef Harper FE, Maricq HR, Turner RE, Lidman RW, LeRoy EC (1982) A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. Am J Med 72:883–888PubMedCrossRef
27.
Zurück zum Zitat Nagy Z, Czirják L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud’s disease. JEADV 18:62–68PubMed Nagy Z, Czirják L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud’s disease. JEADV 18:62–68PubMed
28.
Zurück zum Zitat Kabasakal Y, Elvins DM, Ring EF, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512PubMedCrossRef Kabasakal Y, Elvins DM, Ring EF, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512PubMedCrossRef
29.
Zurück zum Zitat Furtado RNV, Pucinelli ML, Cristo VV, Andrade LE, Sato EI (2002) Scleroderma like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud’s phenomenon in SEL patients. Lupus 11:35–41PubMedCrossRef Furtado RNV, Pucinelli ML, Cristo VV, Andrade LE, Sato EI (2002) Scleroderma like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud’s phenomenon in SEL patients. Lupus 11:35–41PubMedCrossRef
30.
Zurück zum Zitat Nakano M, Ohuchi Y, Hasegawa H, Kuroda T, Ito S, Gejyo F (2000) Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J Rheumatol 27:1403–1407PubMed Nakano M, Ohuchi Y, Hasegawa H, Kuroda T, Ito S, Gejyo F (2000) Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J Rheumatol 27:1403–1407PubMed
31.
Zurück zum Zitat Fritzler MJ, Kinsella TD (1980) The CREST syndrome: a distinct serologic entirety with anticentromere antibodies. Am J Med 69:520–526PubMedCrossRef Fritzler MJ, Kinsella TD (1980) The CREST syndrome: a distinct serologic entirety with anticentromere antibodies. Am J Med 69:520–526PubMedCrossRef
32.
Zurück zum Zitat Ferri C, Bernini L, Cecchetti R et al (1991) Cutaneous and serologic subset of systemic sclerosis. J Rheumatol 18:1826–1832PubMed Ferri C, Bernini L, Cecchetti R et al (1991) Cutaneous and serologic subset of systemic sclerosis. J Rheumatol 18:1826–1832PubMed
33.
Zurück zum Zitat Sarkozi J, Bookman AM, Lee P, Keystone EC, Fritzler MJ (1987) Significance of anticentromere antibody in idiopathic Raynaud’s syndrome. Am J Med 83:893–898PubMedCrossRef Sarkozi J, Bookman AM, Lee P, Keystone EC, Fritzler MJ (1987) Significance of anticentromere antibody in idiopathic Raynaud’s syndrome. Am J Med 83:893–898PubMedCrossRef
34.
Zurück zum Zitat Lambova SN, Müller-Ladner U (2009) The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29:1263–1271PubMedCrossRef Lambova SN, Müller-Ladner U (2009) The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29:1263–1271PubMedCrossRef
35.
Zurück zum Zitat Ingegnolli F, Zeni S, Meani L, Soldi A, Lurati A, Fantini F (2005) Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 11:295–298CrossRef Ingegnolli F, Zeni S, Meani L, Soldi A, Lurati A, Fantini F (2005) Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 11:295–298CrossRef
36.
Zurück zum Zitat Bongard O, Bounameaux H, Miescher PA, deMoerloose P (1995) Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 4:142–144PubMedCrossRef Bongard O, Bounameaux H, Miescher PA, deMoerloose P (1995) Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 4:142–144PubMedCrossRef
37.
Zurück zum Zitat Jouanny P, Schmidt C, Feldmann L, Schmitt J (1994) Focus on a quick reading of nailfold capillaroscopy. J Mal Vasc 19:206–209PubMed Jouanny P, Schmidt C, Feldmann L, Schmitt J (1994) Focus on a quick reading of nailfold capillaroscopy. J Mal Vasc 19:206–209PubMed
38.
Zurück zum Zitat Fitzgerald O, Hess EV, O’Connor GT, Spencer-Green G (1988) Prospective study of the evolution of Raynaud’s phenomenon. Am J Med 84:718–726PubMedCrossRef Fitzgerald O, Hess EV, O’Connor GT, Spencer-Green G (1988) Prospective study of the evolution of Raynaud’s phenomenon. Am J Med 84:718–726PubMedCrossRef
39.
Zurück zum Zitat Luggen M, Belhorn L, Evans T, Fitzgerald O, Spencer-Green G (1995) The evolution of Raynaud’s phenomenon: a longterm prospective study. J Rheumatol 22:2226–2232PubMed Luggen M, Belhorn L, Evans T, Fitzgerald O, Spencer-Green G (1995) The evolution of Raynaud’s phenomenon: a longterm prospective study. J Rheumatol 22:2226–2232PubMed
40.
Zurück zum Zitat Tektonidou M, Kaskani E, Skopouli FN, Moutsopoulos HM (1999) Microvascular abnormalities in Sjögren’s syndrome: nailfold capillaroscopy. Rheumatology 38:826–830PubMedCrossRef Tektonidou M, Kaskani E, Skopouli FN, Moutsopoulos HM (1999) Microvascular abnormalities in Sjögren’s syndrome: nailfold capillaroscopy. Rheumatology 38:826–830PubMedCrossRef
41.
Zurück zum Zitat Redisch W (1970) Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis 29:244–253PubMedCrossRef Redisch W (1970) Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis 29:244–253PubMedCrossRef
42.
Zurück zum Zitat Zimmerman C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS (1998) The concurrence of rheumatoid arthritis and limited systemic sclerosis. Clinical and serological characteristics of an overlap syndrome. Arthr Rheum 41:1938–1945CrossRef Zimmerman C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS (1998) The concurrence of rheumatoid arthritis and limited systemic sclerosis. Clinical and serological characteristics of an overlap syndrome. Arthr Rheum 41:1938–1945CrossRef
43.
Zurück zum Zitat Ohtsuka T, Tamura T, Yamakage A, Yamazaki S (1998) The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Br J Dermatol 139:622–629PubMedCrossRef Ohtsuka T, Tamura T, Yamakage A, Yamazaki S (1998) The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Br J Dermatol 139:622–629PubMedCrossRef
Metadaten
Titel
Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud’s phenomenon
verfasst von
Slavica Pavlov-Dolijanovic
Nemanja S. Damjanov
Roksanda M. Stojanovic
Nada Z. Vujasinovic Stupar
Dejana M. Stanisavljevic
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 10/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2109-2

Weitere Artikel der Ausgabe 10/2012

Rheumatology International 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.